glutathione s-transferase omega 1-1 is a target of cytokine

glutathione s-transferase omega 1-1 is a target of cytokine Unveiling the Role Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications Glutathione transferase omega 1-1 (GSTO1-1)

Name: glutathione s-transferase omega 1-1 is a target of cytokine Unveiling the Role Protein in Breast Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications Glutathione transferase omega 1-1 (GSTO1-1)
Brand: vanierexcavation.com
SKU: 80652507220
Price: 25.82 USD
Availability: InStock
Rating: 4.2403 (28 reviews)

Glutathione transferase omega 1 1 (GSTO1 1) can effect the inter cell transfer of cisplatin resistance through the exosomal route ScienceDirect Mechanistic evaluation and transcriptional signature of a glutathione S transferase omega 1 inhibitor Nature Communications Glutathione S Transferase Omega 1 1 Is a Target of Cytokine Release Inhibitory Drugs and May Be Responsible for Their Effect on Interleukin 1 Posttranslational Processing* Journal of Biological Chemistry A Role for Glutathione Transferase Omega 1 (GSTO1 1) in the Glutathionylation Cycle Journal of Biological Chemistry Glutathione Stransferase omega 1 inhibition activates JNKmediated apoptotic response in breast cancer stem cells Manupati 2019 The FEBS Journal Wiley Online Library

SKU: 80652507220 · From vanierexcavation.com

4.2

USD25.82 USD65.82

Pay in 4 interest-free payments of $6.46 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

For example, a speaker might disseminate sound throughout a room, or a flashlight might disseminate light in a dark space

Sometimes a dye is used to more clearly see a SLAP injury

200 Consequently, numerous preclinical and clinical efforts have targeted pathways through small-molecule inhibitors of Notch (e.g., -secretase inhibitors), Hedgehog (e.g., Smoothened (SMO) inhibitors), and PI3K/AKT/mTOR (e.g., rapamycin analogs, pan-PI3K inhibitors) to deplete CSC populations